Avience Biomedicals (NSE:AVIENCE) Cash Flow for Dividends: ₹0.0 Mil (TTM As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Cash Flow for Dividends?

Avience Biomedicals NSE:AVIENCE 5 Cash Flow for Dividends is ₹0.0 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's cash flow for dividends for the three months ended in Jan. 2026 was ₹0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jan. 2026 was ₹0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Avience Biomedicals Cash Flow for Dividends Related Terms

Avience Biomedicals Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Cash Flow for Dividends Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Cash Flow for Dividends
0.00 0.00 0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Cash Flow for Dividends 0.00 0.00 0.00 0.00
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0.0 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Cash Flow for Dividends of ₹0.0 Mil as of Jan. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Avience Biomedicals and its competitors.
Is Avience Biomedicals' Cash Flow for Dividends too high?
Avience Biomedicals' current Cash Flow for Dividends is ₹0.0 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Cash Flow for Dividends compare to ABT and SYK?
Avience Biomedicals' Cash Flow for Dividends of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Avience Biomedicals and its competitors. Avience Biomedicals's current Cash Flow for Dividends is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Cash Flow for Dividends of ₹0.0 Mil. The current Cash Flow for Dividends is ₹0.0 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Cash Flow for Dividends is ₹0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price